Literature DB >> 12084270

The role of complementary medicine in the treatment of prostate cancer.

I Yip1, N Duran.   

Abstract

Complementary and alternative medicine (CAM) has recently attracted national attention in the United States because of its widespread use and associated cost. CAM covers a broad spectrum of healing philosophies and approaches. Despite its widespread use, little is known about its safety, efficacy, cost effectiveness, and mechanism of action. The role of CAM in the management of prostate cancer is becoming more apparent with its rise in use among patients who are suffering from prostate cancer. This trend is patient-driven and reflects the change in values perceived by patients toward conventional medical treatment. In this review, several complementary therapies that can be used for prevention and treatment of prostate cancer are discussed. These therapies were selected because they are supported by scientific evidence. The popularity of CAM continues to grow and CAM is here to stay. Health care professionals can no longer afford to ignore or to treat CAM as an entity outside of conventional science. To acknowledge and to monitor its use among our patients may in the future help evaluate the safety and efficacy of CAM. Our current challenge is to move the field of CAM forward scientifically and systematically with wisdom and reasoning.

Entities:  

Mesh:

Year:  2001        PMID: 12084270     DOI: 10.1007/s11934-001-0084-y

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  62 in total

1.  Inhibition of proliferation of prostate cancer cells by a 19-nor-hexafluoride vitamin D3 analogue involves the induction of p21waf1, p27kip1 and E-cadherin.

Authors:  M J Campbell; E Elstner; S Holden; M Uskokovic; H P Koeffler
Journal:  J Mol Endocrinol       Date:  1997-08       Impact factor: 5.098

2.  Influence of isoflavones in soy protein isolates on development of induced prostate-related cancers in L-W rats.

Authors:  M Pollard; P H Luckert
Journal:  Nutr Cancer       Date:  1997       Impact factor: 2.900

3.  Herbal therapy PC-SPES: in vitro effects and evaluation of its efficacy in 69 patients with prostate cancer.

Authors:  A de la Taille; R Buttyan; O Hayek; E Bagiella; A Shabsigh; M Burchardt; T Burchardt; D K Chopin; A E Katz
Journal:  J Urol       Date:  2000-10       Impact factor: 7.450

4.  1 alpha,25-Dihydroxyvitamin D (calcitriol) inhibits the invasiveness of human prostate cancer cells.

Authors:  G G Schwartz; M H Wang; M Zang; R K Singh; G P Siegal
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1997-09       Impact factor: 4.254

5.  Intake of carotenoids and retinol in relation to risk of prostate cancer.

Authors:  E Giovannucci; A Ascherio; E B Rimm; M J Stampfer; G A Colditz; W C Willett
Journal:  J Natl Cancer Inst       Date:  1995-12-06       Impact factor: 13.506

6.  Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey.

Authors:  D M Eisenberg; R B Davis; S L Ettner; S Appel; S Wilkey; M Van Rompay; R C Kessler
Journal:  JAMA       Date:  1998-11-11       Impact factor: 56.272

7.  Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation.

Authors:  C L Hanchette; G G Schwartz
Journal:  Cancer       Date:  1992-12-15       Impact factor: 6.860

8.  Adult dietary intake and prostate cancer risk in Utah: a case-control study with special emphasis on aggressive tumors.

Authors:  D W West; M L Slattery; L M Robison; T K French; A W Mahoney
Journal:  Cancer Causes Control       Date:  1991-03       Impact factor: 2.506

9.  Lycopene is a more potent inhibitor of human cancer cell proliferation than either alpha-carotene or beta-carotene.

Authors:  J Levy; E Bosin; B Feldman; Y Giat; A Miinster; M Danilenko; Y Sharoni
Journal:  Nutr Cancer       Date:  1995       Impact factor: 2.900

10.  Cancer mortality correlation studies--III: statistical associations with dietary selenium intakes.

Authors:  G N Schrauzer; D A White; C J Schneider
Journal:  Bioinorg Chem       Date:  1977
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.